Social Robot Interaction for Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a friendly robot can reduce apathy (a lack of interest or emotion) in older adults with mild to moderate cognitive impairment living in long-term care facilities. Participants will engage with either a humanoid or dog-like robot in activity sessions, while another group will continue their usual activities without robots. Researchers will compare the two groups to determine if the robots improve engagement and interest levels. This study is ideal for individuals who have lived in a care facility for more than three months, show mild to moderate cognitive issues, and experience noticeable apathy. As a Phase 1, Phase 2 trial, this research focuses on understanding how the treatment works in people and measuring its effectiveness in an initial, smaller group, offering participants a chance to contribute to groundbreaking research.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this socially assistive robot system is safe for cognitively impaired older adults?
Research shows that socially assistive robots are being explored to help people with memory and thinking problems, such as those seen in dementia. Various studies have tested these robots, yielding encouraging results. Past research demonstrated that these robots helped reduce feelings of apathy—meaning a lack of interest or enthusiasm—in older adults, suggesting they can engage people positively.
So far, studies have not identified any serious safety issues with these robots. Participants generally respond well to them. The robots interact in a friendly and supportive manner, making them suitable for long-term care settings. As this trial begins, it aims to test the effectiveness and safety of the robots. While no major safety problems have been found so far, the study will monitor for potential risks as more people use the robots.
Overall, current research suggests that using socially assistive robots is safe. Participants can expect a positive experience with these robots, which are designed to improve social interaction and reduce apathy.12345Why are researchers excited about this trial?
Researchers are excited about the Socially Assistive Robot Activity because it offers a novel approach to managing cognitive impairment. Unlike traditional treatments that might involve medication or human-led therapy, this method uses interactive robots to engage participants. The unique aspect is the combination of humanoid and dog robots, which could provide diverse social interactions and mental stimulation. This innovative approach aims to enhance cognitive function and quality of life in a way that current treatments may not fully address.
What evidence suggests that this socially assistive robot activity is effective for reducing apathy in cognitively impaired older adults?
Research has shown that socially assistive robots (SARs) can help reduce symptoms like depression and anxiety in people with dementia. Studies have found that interacting with these robots can bring happiness and positive feelings. For people with Alzheimer's, SARs have supported daily activities and improved social interactions. Reviews of multiple studies indicate that these robots significantly reduce anxiety and restlessness, although they don't seem to improve thinking skills. In this trial, participants in the "Socially Assistive Robot Activity" arm will interact with either a humanoid robot or a dog robot, which may help reduce lack of interest among older adults with memory and thinking problems. Meanwhile, participants in the "Usual Activity Program" arm will engage in regular activities without robot interaction.12467
Are You a Good Fit for This Trial?
This trial is for older adults with mild to moderate cognitive impairment and apathy, living in long-term care for over 3 months. Participants should have certain scores on cognitive tests (SAGE, AD8, DSRD) and show symptoms of apathy (AES-C score of 30+). It's not suitable for those with severe cognitive issues, physical limitations that prevent participation, sensory impairments without correction, non-English speakers or those who are acutely or terminally ill.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either usual activity programs or usual activity programs plus robotic activities, attending two sessions per week for eight weeks
Follow-up
Participants are monitored for changes in apathy and cognitive function using various assessments
What Are the Treatments Tested in This Trial?
Interventions
- Socially Assistive Robot Activity
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator